Cargando…

Getting to the (germinal) center of humoral immune responses to SARS-CoV-2

Long-term protection against SARS-CoV-2 requires effective and durable immunity. In this issue of Cell, two papers closely examine germinal centers, the physiological birthplace of adaptive immunity, to quantify the specificity, breadth, magnitude, and persistence of systemic and local humoral immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Tangye, Stuart G., Burnett, Deborah L., Bull, Rowena A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928419/
https://www.ncbi.nlm.nih.gov/pubmed/35303427
http://dx.doi.org/10.1016/j.cell.2022.02.018
_version_ 1784670637338394624
author Tangye, Stuart G.
Burnett, Deborah L.
Bull, Rowena A.
author_facet Tangye, Stuart G.
Burnett, Deborah L.
Bull, Rowena A.
author_sort Tangye, Stuart G.
collection PubMed
description Long-term protection against SARS-CoV-2 requires effective and durable immunity. In this issue of Cell, two papers closely examine germinal centers, the physiological birthplace of adaptive immunity, to quantify the specificity, breadth, magnitude, and persistence of systemic and local humoral immune responses following natural infection with, or vaccination against, SARS-CoV-2.
format Online
Article
Text
id pubmed-8928419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89284192022-03-17 Getting to the (germinal) center of humoral immune responses to SARS-CoV-2 Tangye, Stuart G. Burnett, Deborah L. Bull, Rowena A. Cell Preview Long-term protection against SARS-CoV-2 requires effective and durable immunity. In this issue of Cell, two papers closely examine germinal centers, the physiological birthplace of adaptive immunity, to quantify the specificity, breadth, magnitude, and persistence of systemic and local humoral immune responses following natural infection with, or vaccination against, SARS-CoV-2. Elsevier Inc. 2022-03-17 2022-03-17 /pmc/articles/PMC8928419/ /pubmed/35303427 http://dx.doi.org/10.1016/j.cell.2022.02.018 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preview
Tangye, Stuart G.
Burnett, Deborah L.
Bull, Rowena A.
Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title_full Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title_fullStr Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title_full_unstemmed Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title_short Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
title_sort getting to the (germinal) center of humoral immune responses to sars-cov-2
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928419/
https://www.ncbi.nlm.nih.gov/pubmed/35303427
http://dx.doi.org/10.1016/j.cell.2022.02.018
work_keys_str_mv AT tangyestuartg gettingtothegerminalcenterofhumoralimmuneresponsestosarscov2
AT burnettdeborahl gettingtothegerminalcenterofhumoralimmuneresponsestosarscov2
AT bullrowenaa gettingtothegerminalcenterofhumoralimmuneresponsestosarscov2